4-iodo-2,5-dimethoxyphenylisopropylamine has been researched along with Glaucoma, Suspect in 2 studies
4-iodo-2,5-dimethoxyphenylisopropylamine: RN given refers to unlabeled parent cpd without isomeric designation; a serotonin agonist
2-(4-iodo-2,5-dimethoxyphenyl)-1-methylethylamine : An organoiodine compound that is amphetamine bearing two methoxy substituents at positions 2 and 5 as well as an iodo substituent at position 4.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| May, JA | 1 |
| Chen, HH | 1 |
| Rusinko, A | 1 |
| Lynch, VM | 1 |
| Sharif, NA | 2 |
| McLaughlin, MA | 1 |
| Kelly, CR | 1 |
| McLaughlin, M | 1 |
2 other studies available for 4-iodo-2,5-dimethoxyphenylisopropylamine and Glaucoma, Suspect
| Article | Year |
|---|---|
A novel and selective 5-HT2 receptor agonist with ocular hypotensive activity: (S)-(+)-1-(2-aminopropyl)-8,9-dihydropyrano[3,2-e]indole.
Topics: Administration, Topical; Animals; Antihypertensive Agents; Blood Pressure; CHO Cells; Cricetinae; Do | 2003 |
Human trabecular meshwork cells express functional serotonin-2A (5HT2A) receptors: role in IOP reduction.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphetamines; Animals; Calcium; Child; Child, Preschool; | 2006 |